To Homepage

Videos about Copeptin

Mirjam Christ-Crain – New approaches in the differential diagnosis of Diabetes insipidus

European Journal of Endocrinology Award Lecture, ECE 2019

ece-2019-award-lecture-diagnosis-diabetes-insipidus

Watch Award Lecture ›

B·R·A·H·M·S Copeptin proAVP. Early and Safe Rule-out of Acute Myocardial Infarction (AMI)

Combining the markers Copeptin and Troponin allows a safe and rapid rule-out of myocardial infarction at presentation. The efficacy and safety of this strategy has been proven in the BIC-8 prospective, randomized multicenter study.

Safe and early rule-out of Myocardial Infarction on admission with Copeptin

We now know that we can discharge patients to home with a double-normal measurement of Troponin and Copeptin due to this safety, earlier than with the standard procedure. This procedure is effective and safe." Prof. Evangelos Giannitsis, Heidelberg

Early Rule-out of Acute Myocardial Infarction with Copeptin – Professor Martin Möckel Interview

„Thanks to the Copeptin biomarker, clinics can better manage overcrowded Emergency Departments ... We have implemented a new algorithm using Copeptin and Troponin at the ED at the Charité now that our study has been published“ Principal investigator of the Biomarkers in Cardiology (BIC)-8 interventional study Prof. Martin Möckel

Early Rule-out of Acute Myocardial Infarction with Copeptin – An Interview with Bertil Lindahl

interview with Bertil Lindahl, Uppsala Clinical Research Centre, Uppsala University, Sweden

Not all products are CE marked or have 510(k) clearance for sale in the U.S. Availability of products in each country depends on local regulatory marketing authorization status.